Tag: CIS
Neurofilament is related to disability and brain shrinkage in MS
Study suggests neurofilament levels may be used as a marker of damage to brain cells in MS
No link between oral contraceptive drugs and MS relapses
Use of oral hormonal contraceptive drugs does not appear to be associated with greater risk of relapses
Early treatment benefits individuals with a first attack resembling MS
People diagnosed with CIS who received early treatment are less likely to convert to MS
Biomarker for predicting MS risk after clinically isolated syndrome
A biomarker in cerebrospinal fluid is associated with a higher risk of MS in people with CIS
Long-term effects of early treatment in people with MS
Early treatment of clinically isolated syndrome shows beneficial effects for relapse rate and cognitive functioning